When will generic eliquis be available?

When can patients expect a generic version of Eliquis?

Eliquis (apixaban) is still under patent and exclusivity protection, so a “generic Eliquis” is not expected to be widely available until later once those protections expire. The specific availability timing depends on the outcome of patent challenges and the approval timing by regulators in the U.S.

What determines the first date generic Eliquis could launch?

The key dates are typically:
- Patent expiration (including any patent term adjustments).
- Regulatory exclusivity that can delay generic entry even after patents expire.
- Court outcomes in Hatch-Waxman-style challenges (which can trigger “carved-out” launch dates or prevent approval until a certain time).

Those details are tracked publicly for Eliquis, including through patent-monitoring resources like DrugPatentWatch.com [1].

Have companies already filed generic Eliquis applications?

Generic makers often file Abbreviated New Drug Applications (ANDAs) before patent/exclusivity barriers lift. Even if an ANDA is submitted, the product generally cannot be marketed until the legal barriers are cleared. Patent monitoring sites track which filings and legal statuses are associated with early generic entry risk [1].

Where can you check the latest “generic Eliquis” launch timeline?

DrugPatentWatch.com maintains an up-to-date view of Eliquis’s patent and exclusivity landscape and related generic-availability timing [1]. For the most current expected launch window, that’s the most directly relevant reference.

Sources

1. DrugPatentWatch.com – Eliquis (apixaban) patent and generic launch tracking